Oncology & Cancer

Use of PPIs tied to cognitive issues in breast cancer survivors

(HealthDay)—Use of acid reflux drugs (proton pump inhibitors [PPIs]) during and after cancer treatment may be tied to impaired memory and concentration in breast cancer survivors, according to a study recently published ...

Diseases, Conditions, Syndromes

No chemopreventive effect seen for H2RAs in barrett's esophagus

(HealthDay)—For patients with Barrett's esophagus (BE), proton pump inhibitor (PPI) but not histamine-2 receptor antagonist (H2RA) use is associated with reduced risk of neoplastic progression, according to research published ...

Alzheimer's disease & dementia

Antiulcer drugs do not increase risk of Alzheimer's disease

The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland. Proton pump inhibitors are a type of antiulcer drug that is commonly used among ...

Diseases, Conditions, Syndromes

Electronic alert cuts proportion of IV proton pump inhibitors

(HealthDay)—An electronic alert triggered on order of intravenous (IV) proton pump inhibitors (PPI) can decrease the proportion of IV PPIs ordered, according to a research letter published online Jan. 19 in JAMA Internal ...

Diseases, Conditions, Syndromes

Lower risk of dabigatran-tied bleeding with gastroprotection

(HealthDay)—For patients taking dabigatran, the risk of gastrointestinal bleeding (GIB) is reduced with use of gastroprotective agents, according to a study published in the September issue of Gastroenterology.

Diseases, Conditions, Syndromes

Review: radioablation offers no benefit for GERD patients

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), evidence shows no difference in physiologic parameters for treatment with a radiofrequency ablation technique known as Stretta versus sham or proton ...

page 15 from 19